BR9713044A - Composto, uso de um composto, processo para sua preparação,e, formulação farmacêutica. - Google Patents

Composto, uso de um composto, processo para sua preparação,e, formulação farmacêutica.

Info

Publication number
BR9713044A
BR9713044A BR9713044-3A BR9713044A BR9713044A BR 9713044 A BR9713044 A BR 9713044A BR 9713044 A BR9713044 A BR 9713044A BR 9713044 A BR9713044 A BR 9713044A
Authority
BR
Brazil
Prior art keywords
compound
preparation
pharmaceutical formulation
processes
treatment
Prior art date
Application number
BR9713044-3A
Other languages
English (en)
Inventor
Duncan Robertson Rae
Samuel George Gibson
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BR9713044A publication Critical patent/BR9713044A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

"COMPOSTO, USO DE UM COMPOSTO, PROCESSO PARA SUA PREPARAçãO, E, FORMULAçãO FARMACêUTICA". A presente invenção diz respeito a certos novos derivados de piperidina, a processos para seu preparo, a formulações farmacêuticas contendo-os, e a seu uso em terapia médica, particularmente no tratamento de distúrbios psicóticos.
BR9713044-3A 1996-11-14 1997-11-12 Composto, uso de um composto, processo para sua preparação,e, formulação farmacêutica. BR9713044A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96203175 1996-11-14
PCT/EP1997/006321 WO1998021206A1 (en) 1996-11-14 1997-11-12 Piperidine derivatives

Publications (1)

Publication Number Publication Date
BR9713044A true BR9713044A (pt) 2000-04-11

Family

ID=8224578

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9713044-3A BR9713044A (pt) 1996-11-14 1997-11-12 Composto, uso de um composto, processo para sua preparação,e, formulação farmacêutica.

Country Status (20)

Country Link
US (1) US6288085B1 (pt)
EP (1) EP0941225A1 (pt)
JP (1) JP2001508044A (pt)
KR (1) KR20000053217A (pt)
CN (1) CN1092655C (pt)
AR (1) AR010289A1 (pt)
AU (1) AU722224B2 (pt)
BR (1) BR9713044A (pt)
CA (1) CA2271832A1 (pt)
CZ (1) CZ172399A3 (pt)
HU (1) HUP9904526A3 (pt)
IL (1) IL122072A (pt)
NO (1) NO992302L (pt)
NZ (1) NZ335631A (pt)
PL (1) PL333323A1 (pt)
RU (1) RU2183624C2 (pt)
TR (1) TR199901385T2 (pt)
TW (1) TW374085B (pt)
WO (1) WO1998021206A1 (pt)
ZA (1) ZA979781B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2616899A (en) * 1998-01-09 1999-07-26 Akzo Nobel N.V. Use of phenylthienylmethylene piperidine derivatives in the manufacture of a medicament for the treatment of depression
AU2716599A (en) * 1998-01-09 1999-07-26 Akzo Nobel N.V. Use of phenylthienylmethylene piperidine derivative in the manufacture of a medicament for the treatment of movement disorders
BR0316747A (pt) * 2002-12-18 2005-10-18 Fmc Corp Piperidinas n-(arilmetil substituìdas)-4-(metil dissubstituìdas) e piperazinas
EA200700117A1 (ru) 2004-06-24 2007-06-29 Инсайт Корпорейшн N-замещенные пиперидины и их применение в качестве фармацевтических препаратов
JP2008504279A (ja) * 2004-06-24 2008-02-14 インサイト・コーポレイション アミド化合物およびその医薬としての使用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL88235C (pt) 1950-12-05
GB1242169A (en) * 1969-04-09 1971-08-11 Ucb Sa Piperidine derivatives
GB1320481A (en) * 1971-01-11 1973-06-13 Pfizer Ltd Substituted gem-diaryl ethylene derivatives and therapeutic compositions thereof
CH587845A5 (en) * 1973-07-17 1977-05-13 Sandoz Ag New piperidylidene-benzo-cyclohepta-thiophenes prodn. - by dehydrating corresp. alcohols, useful e.g. as neuroleptics and analgesics
US4073912A (en) * 1976-10-12 1978-02-14 Smithkline Corporation Piperidylidene derivatives of benzo-fused xanthenes, thioxanthenes and dibenzoxepins and antipsychotic use thereof
US4485107A (en) 1982-11-01 1984-11-27 Janssen Pharmaceutica N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
US4797489A (en) * 1987-12-02 1989-01-10 American Home Products Corp. Adamantyl- and fluorenyl-arylpiperazines and -arylpiperidines
GB8900382D0 (en) 1989-01-09 1989-03-08 Janssen Pharmaceutica Nv 2-aminopyrimidinone derivatives
EP0465254B1 (en) 1990-07-06 1996-11-13 Yoshitomi Pharmaceutical Industries, Ltd. Fused thiophene compounds and uses thereof
US5683998A (en) * 1991-04-23 1997-11-04 Toray Industries, Inc. Tricyclic triazolo derivatives, processes for producing the same and the uses of the same

Also Published As

Publication number Publication date
JP2001508044A (ja) 2001-06-19
IL122072A0 (en) 1998-03-10
CZ172399A3 (cs) 1999-11-17
IL122072A (en) 2001-03-19
RU2183624C2 (ru) 2002-06-20
NO992302L (no) 1999-05-14
TW374085B (en) 1999-11-11
ZA979781B (en) 1998-06-08
PL333323A1 (en) 1999-12-06
AU5552098A (en) 1998-06-03
HUP9904526A3 (en) 2000-12-28
EP0941225A1 (en) 1999-09-15
CN1240444A (zh) 2000-01-05
HUP9904526A2 (hu) 2000-11-28
AU722224B2 (en) 2000-07-27
CN1092655C (zh) 2002-10-16
TR199901385T2 (xx) 1999-11-22
US6288085B1 (en) 2001-09-11
AR010289A1 (es) 2000-06-07
WO1998021206A1 (en) 1998-05-22
NO992302D0 (no) 1999-05-12
KR20000053217A (ko) 2000-08-25
NZ335631A (en) 2000-10-27
CA2271832A1 (en) 1998-05-22

Similar Documents

Publication Publication Date Title
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
BR9006924A (pt) Formulacao para tratamento de sintomas e doencas,uso de formulacao para o tratamento de sintomas e doencas,metodo para o tratamento de sintomas e doencas,distribuicao de agentes medicinais e terapeuticos para o tratamento de sintomas e doencas e combinacao para administracao em mamiferos
ID28003A (id) Turunan-turunan adamantana
ES2133785T3 (es) Inhibidores de metaloproteinasas.
FI961809A0 (fi) Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit
BG101118A (en) Therapeutical compounds
AR019853A1 (es) Derivado del acido 3-aril-2-hidroxipropionico, proceso e intermediario para su preparacion, formulaciones farmaceuticas, uso de dicho compuesto en laelaboracion de un medicamento, metodo para la profilaxis y/o tratamiento de trastornos clinicos asociados con la resistencia a la insulina, y formulaci
ES2173111T3 (es) Uso de fenserina para la preparacion de medicamentos para el tratamiento de desordenes cognoscitivos.
FI903153A0 (fi) 11b-aryl-4-estrener, foerfarande foer deras framstaellning samt deras anvaendning som laekemedel.
BR9908510A (pt) Uso de um composto, composto, processo para a preparação de um composto, composição farmacêutica, e, processo de tratar um paciente que sofre de, ou em risco de, uma doença micobacteriana
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
BR0114344A (pt) Retinóides para o tratamento de enfisema
BR9808077A (pt) Combinação, formulação farmacêutica, processo para o tratamento de um distúrbio psicótico em um aninal, usos de mirtazapina e de um agente antipsicótico, e, pacote para paciente
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
BR9813318A (pt) Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
DE69200711T2 (de) Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung.
BR9506748A (pt) Compostos preparação farmacêutica utilização de um composto e processos para o tratamento de um indivíduo sofrendo de dor e para a preparação de um composto
BR9713044A (pt) Composto, uso de um composto, processo para sua preparação,e, formulação farmacêutica.
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
BR9611276A (pt) Composto formulação farmacêutica processo para tratamento ou profilaxia de doenças ou condições de seres humanos e uso de um composto
PT656209E (pt) Derivados de melatonina para uso no tratamento de perturbacoes de dessincronizacao
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
PT90816A (pt) Processo para a preparacao de composicoes farmaceuticas contendo analogos de 2',5'-oligoadenilato
BR0111055A (pt) Formulação farmacêutica, e, processo para a preparação e uso da mesma
BR9406865A (pt) Uso de um sal farmaceuticamente aceitável de ropivacaina na fabricaçao de um produto farmaceutico processo para o tratamento de uma pessoa necessitando de alivio da dor e preparaçao farmaceutica

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1834 DE 01/03/2006.